Home › NDC Lookup › Ingredients › Lidocaine And Camphor › 84991-0208-01
Olu Pain Management lidocaine and camphor .01 g/g; .04 g/g Patch, 15 patches — NDC 84991-0208-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Olu Pain Management lidocaine and camphor .01 g/g; .04 g/g Patch, 15 patches — NDC 84991-0208-1 (Billing 84991-0208-01)

by Olakino Therapeutics LLC · 3 POUCH in 1 BOX / 5 PATCH in 1 POUCH / 8.5 g in 1 PATCH

This is a package of 15 patches of Olu Pain Management lidocaine and camphor .01 g/g; .04 g/g Patch from Olakino Therapeutics LLC, marketed since Dec 2024 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 84991-0208-01
🏷️ FDA NDC (as labeled) 84991-0208-1 billing pads the package segment with a zero
This package
Contains15 patches Pack sizes2 compare ↓
Main listing for product 84991-0208 · Also comes in: 5 patches 84991-0208-5
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 84991-0208-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
84991 labeler · 0208 product · 1 package
Package marketed since
Dec 24, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
15 EA per package
Barcode (UPC-A, from the NDC)
3 8499102081 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 84991-0208-1
Product NDC 84991-0208
11-digit billing NDC 84991020801
NCPDP billing unit EA — each (per item)
RxCUI 2700664
UNII N20HL7Q941, 98PI200987
Application # M017
SPL Set ID 2a41a621-c6f7-5819-e063-6394a90ae67d
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-12-24
Route CUTANEOUS
Dosage form PATCH
Substance CAMPHOR (NATURAL); LIDOCAINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 087310
GCN 57186
HICL code 050302
Ingredient (HICL) Lidocaine/Camphor
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5H
Therapeutic class — specific (HIC3) Topical Local Anesthetics
AHFS code 72:00.00.00
AHFS class Local Anesthetics
FDB label name OLU PAIN MANAGEMENT 4-1% PATCH
FDB brand name Olu
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 087310
  • GCN: 57186
  • HICL (First Databank): 050302
  • AHFS class code: 72:00.00.00
  • RxCUI (RxNorm): 2700664
Why two NDCs? The FDA registers this code as 84991-0208-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 84991-0208-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name OLU PAIN MANAGEMENT 4-1% PATCH Ingredient Lidocaine/Camphor
🧪 What is this product?

Olu Pain Management is an over-the-counter topical patch containing lidocaine and camphor. Lidocaine is a local anesthetic typically used to numb pain at the skin surface, while camphor is commonly used in pain-relief products for its cooling and soothing sensations. This patch is applied directly to the skin over areas of discomfort and is marketed as an OTC monograph drug, meaning it follows FDA's established safety and effectiveness guidelines for this category of product.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 5 patches
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
84991-0208-01 You're viewing this Main listing 3 POUCH in 1 BOX / 5 PATCH in 1 POUCH / 8.5 g in 1 PATCH 2024-12-24 — Active
84991-0208-05 84991-0208-5 5 PATCH in 1 POUCH / 8.5 g in 1 PATCH 2024-12-24 — Active

Pack size FAQ

What quantity is in this package?
This package contains 15 patches — 3 pouch in 1 box / 5 patch in 1 pouch / 8.5 g in 1 patch.
How does this package differ from NDC 84991-0208-05?
Both are Olu Pain Management lidocaine and camphor .01 g/g; .04 g/g Patch — the drug itself is identical. This page's package is the 15 patches one, while NDC 84991-0208-05 is the 5 patches package.
What NDC number is used to bill for this package of Olu Pain Management lidocaine and camphor .01 g/g; .04 g/g Patch?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Olu Pain Management .01 g/g; .04 g/g 76420-0956-05 Asclemed 5 patches — — FDA listed —
Olu Pain Management .01 g/g; .04 g/gthis 84991-0208-01 Olakino 15 patches — — FDA listed —
Olu Pain Management .01 g/g; .04 g/g 85534-0102-00 HAWAII 15 patches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Dec 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII H4N855PNZ1
    Alpha-tocopherol is a form of vitamin E, a fat-soluble antioxidant derived from natural or synthetic sources. In medicines, it prevents oils and fats from breaking down and becoming rancid, protecting the product's stability and shelf life.
  • UNII OZ0E5Y15PZ
    A plant extract from arnica flowers, used as a flavoring agent or fragrance component in medicines. It may also provide mild soothing properties to certain topical formulations.
  • UNII PQ6CK8PD0R
    Ascorbic acid, also known as vitamin C, is a white crystalline powder. It serves as an antioxidant to prevent degradation of other ingredients and may also function as a preservative in the formulation.
  • UNII X7B7P649WQ
    A plant extract from boswellia serrata tree resin, used as a natural filler and binding agent in capsules and tablets to add bulk and help hold the formulation together.
  • UNII DO250MG0W6
    A mineral compound containing aluminum that acts as an antacid and buffering agent. It helps neutralize stomach acid and is used as a pH buffer to stabilize the medicine's formulation.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 285CYO341L
    Sodium polyacrylate is a synthetic polymer that absorbs and holds water. In medicines, it acts as a disintegrant, helping tablets break apart quickly in the stomach, and as a binder, holding tablet ingredients together.
  • UNII W4888I119H
    Tartaric acid is a natural organic acid found in grapes and tamarinds. In medicines, it works as a buffer to control acidity, an antioxidant to prevent spoilage, and sometimes a flavoring or binding agent.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

12 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesArnica Extract, Boswellia Extract, Vitamin C, Vitamin E, Ethyl Alcohol, Propylene Glycol, Glycerol, Sodium Polyacrylate, Tartaric Acid, Dihydroxyaluminium Aminoacetate, Methylparaben, Water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerOlakino Therapeutics LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code84991
First marketedDec 2024
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Olakino Therapeutics LLC labeler code 84991

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 19 words ▾

USES For the temporary relief of muscle pain and joint pain associated with: -Backache -Cramps -Soreness -Strains -Discomfort -Neckache

⏱️ Dosage and Administration 56 words ▾

DIRECTIONS Adults and Children 12 Years of Age and Older: -Clean and dry the affected area -Apply gel pad directly onto skin for up to 12 hours -Wash hands immediately after use -Gel pad can be cut into pieces and used on up to 2 body parts at a time -One application per day is recommended

⚠️ Warnings 5 words ▾

WARNINGS: FOR EXTERNAL USE ONLY

🧪 Active Ingredient 8 words ▾

ACTIVE INGREDIENTS Lidocaine 4%

ACTIVE INGREDIENTS Camphor 1%

🧪 Inactive Ingredients 23 words ▾

INACTIVE INGREDIENTS Arnica Extract, Boswellia Extract, Vitamin C, Vitamin E, Ethyl Alcohol, Propylene Glycol, Glycerol, Sodium Polyacrylate, Tartaric Acid, Dihydroxyaluminium Aminoacetate, Methylparaben, Water

🎯 Purpose 5 words ▾

PURPOSE Local Anesthetic

PURPOSE Counterirritant

📄 Do Not Use 34 words ▾

DO NOT USE -On damaged, irritated, or infected skin -With a bandage or heating pad -If you are allergic to any ingredients in this product -In the eyes, nose, or mouth -Otherwise as directed

📄 When Using This Product 12 words ▾

WHEN USING THIS PRODUCT Avoid contact with the eyes, nose, and mouth

📄 Stop Use and Ask a Doctor If 36 words ▾

STOP USE AND ASK DOCTOR IF -Any of the warnings apply to you -Excessive skin irritation develops -Condition worsens -Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

🤰 If Pregnant or Breast-Feeding 10 words ▾

IF PREGNANT OR BREASTFEEDING Ask a healthcare professional before use

📄 Keep Out of Reach of Children 16 words ▾

KEEP OUT OF REACH OF CHILDREN If ingested, seek medical help or contact Poison Control immediately

📄 Package Label / Principal Display Panel 2 words ▾

pouch box

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Olakino Therapeutics LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 5 patches (84991-0208-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Olakino Therapeutics LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 84990-0001-01 · AQBC 84991-0316-01 · Olakino →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.